Pharmacist Focused Updates on CAR T-Cell Therapies from the American Society of Hematology 2024 Annual Meeting
Tracking # 20-1314915
Free
Course overview
The goal of this educational activity is to provide pharmacists including specialty and managed care pharmacists with news and therapeutic updates on the application of CAR-T cell therapy in blood cancers, based on presentations at ASH 2024.
Subject areas
This course counts toward the state boards and subject areas below.
Florida Board of Pharmacy
Pharmacist
Disclosure statements
Ms. Wandersee has no actual or potential conflicts of interest in relation to this program.
The interviewee and clinical reviewer, Issam Hamadeh, PharmD, has disclosed that he has received grant/research support from Hematology Oncology Pharmacy Association, served as a consultant/advisory board member for BMS, and on a speaker bureau for Johnson and Johnson.
The interviewee, James Davis, PharmD, BCOP has disclosed that he has served as a consultant for Janssen Biotech Inc. and BMS, and on the speakers’ bureau for Janssen Biotech Inc.
Susanne Kwas MSHF, BSN, RN, Robin Soboti, RPh, and Susan R. Grady, MSN, RN, as well as the planners, managers, and other individuals, not previously disclosed, who are in a position to control the content of Postgraduate Healthcare Education (PHE) continuing education activities hereby state that they have no relevant conflicts of interest and no financial relationships or relationships to products or devices during the past 12 months to disclose in relation to this activity. PHE is committed to providing participants with a quality learning experience and to improve clinical outcomes without promoting the financial interests of a proprietary business.
All relevant financial relationships have been mitigated.